Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,880 total articles
Getty Images announced its first quarter 2026 financial results with a modest 1.1% revenue increase and a significant reduction in net loss compared to last year. Despite challenges in segments like Agency and microstock, the corporate subscription business grew, and the company maintained its full-year revenue and adjusted EBITDA guidance. The ong…
Perspective Therapeutics reported Q1 2026 financial results showing increased cash reserves to $271 million following a successful equity offering and detailed progress across its three clinical-stage oncology programs targeting neuroendocrine tumors, melanoma, and FAP-positive solid tumors with multiple clinical catalysts expected throughout 2026.…
Oculis Holding AG reported strong Q1 2026 results highlighting significant progress across its late-stage ophthalmology pipeline. The company completed last patient visit in its pivotal Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema with topline data expected in June 2026, planning NDA submission by year-end. Its genotype-driven Licami…
Health Catalyst, a healthcare intelligence company, reported Q1 2026 financial results showing total revenue of $70.8 million, down 11% year-over-year, with adjusted EBITDA of $9.1 million, up 46%. The company undertook a strategic reset focusing on its technology opportunities, resulting in a significant goodwill impairment charge of $95.5 million…
MARA Holdings, Inc. announced its preliminary, unaudited financial results for the first quarter of 2026 and invited investors to a webcast and conference call to discuss the results. The company continues to focus on deploying digital energy technologies to optimize energy systems and reduce energy demands in computing applications.
Roivant Sciences Ltd. announced it will report financial results for Q4 and fiscal year ended March 31, 2026, and provide an update on its biopharmaceutical pipeline on May 20, 2026. The company develops various drug candidates and utilizes nimble subsidiaries to advance their pipeline, aiming to improve patient outcomes.
Immunovant, a clinical-stage immunology company focused on autoimmune diseases, announced it will report its financial results for the fourth quarter and fiscal year ended March 31, 2026, via a webcast and conference call on May 20, 2026. The company will also provide a business update during the call.
Rigetti Computing announced its financial results for Q1 2026, highlighting revenue growth driven by new quantum system sales and technology milestones. The company launched its 108-qubit Cepheus-1-108Q system, expanded international presence, and confirmed strong cash reserves and no debt position to support ongoing R&D and commercial opportunitie…
Medallion Bank has entered into a multi-year strategic partnership with fintech firm Together Loans to expand consumer loan offerings based on cosigner trust rather than credit scores. This marks the Bank's fifth fintech alliance, contributing to a substantial increase in loan originations through strategic partnerships from $203.6 million in 2024 …
Elicio Therapeutics announced its first quarter 2026 financial results, highlighting a net loss of $11.8 million and cash runway expected to extend into Q4 2026 following recent fundraising efforts. The company provided updates on its Phase 2 AMPLIFY-7P study evaluating ELI-002 7P, an immunotherapy targeting KRAS-driven pancreatic ductal adenocarci…
Nasdaq published its end-of-month short interest data as of April 30, 2026, showing a slight increase in short interest shares and days of average volume across its Global Market and Capital Market securities compared to the prior reporting period. Total short interest across all Nasdaq securities rose moderately, indicating stable but marginally h…
CVRx, Inc. reported a 20% increase in total revenue for Q1 2026 to $14.8 million, driven by a 22% growth in U.S. revenue attributed to expanded sales territories and increased awareness of its Barostim device. The company initiated the BENEFIT-HF clinical trial with the first site activated and patient enrolled in Q2 2026. CVRx maintained its 2026 …
Life360, Inc. announced record-first quarter 2026 financial results, highlighted by a 38% year-over-year increase in total revenue to $143.1 million and 17% growth in monthly active users to approximately 97.8 million. The company also reported a 329% increase in advertising revenue to $19.7 million following its Nativo acquisition. Life360's payin…
Abivax SA held its 2026 Annual General Meeting where shareholders approved all board-proposed resolutions including the financial statements for 2025, executive compensation policies, and authorizations for financial transactions. Abivax continues its focus on developing immunoregulatory therapeutics with its lead candidate in Phase 3 trials for ul…
SKYX Platforms Corp. reported record first quarter 2026 revenues of $22 million, a 10% increase year-over-year, marking its ninth consecutive quarter of year-over-year growth. The company improved its gross profit by 16% and increased its gross margin to 30%. SKYX secured $32 million in cash and equivalents, enabling confidence in achieving cash fl…
The Nasdaq Stock Market has announced the delisting of several companies' securities whose shares were suspended and have not traded since various dates between December 2025 and April 2026. Companies impacted include MingZhu Logistics Holdings Limited, Harrison Global Holdings Inc., MSP Recovery, Inc., and others. This action formalizes the remova…
Outset Medical announced that its management will present at the RBC Capital Markets Global Healthcare conference to discuss its pioneering Tablo Hemodialysis System, which improves clinical outcomes while reducing cost and complexity in dialysis treatment. The FDA-cleared system is widely adopted in U.S. healthcare facilities and integrates advanc…
MYR Group Inc., a specialty electrical contracting company operating in the U.S. and Canada, announced its participation in the Wells Fargo Industrials & Materials investor conference on June 10, 2026. Senior executives will meet with institutional investors during the event, which is exclusive to Wells Fargo clients.
HF Foods Group Inc., a distributor of Asian foodservice products across the U.S., reported first quarter 2026 financial results with net revenue increasing 4.5% to $312 million and GAAP net income rising significantly by 188.6% to $1.4 million. Adjusted Net Income slightly decreased by 3.6% to $3.4 million, while Adjusted EBITDA increased 3.8% to $…
Sana Biotechnology reported first quarter 2026 financial results highlighting strategic collaboration with Mayo Clinic to accelerate type 1 diabetes cell therapy development. The company shared positive clinical data from an ongoing islet cell transplant study and announced plans to initiate Phase 1 trials for SC451 (type 1 diabetes) and SG293 (non…
Amplify Energy Corp. announced its Q1 2026 financial and operating results, highlighting a net loss due to unrealized commodity losses but positive adjusted net income and EBITDA. The company secured royalty relief reducing Beta field royalties by 50%, boosting net production by over 600 barrels per day and expected incremental monthly revenue of o…
VirTra, Inc. reported Q1 2026 financial results with total revenue declining 51% year-over-year to $3.5 million, mainly due to timing delays in order deliveries. The company emphasized strong backlog of $25.2 million and expanded engagement across law enforcement, corrections, federal, and international markets, including new drone defense training…
Metagenomi Therapeutics reported first quarter 2026 financial results and key clinical updates, highlighting progress of its lead hemophilia A gene editing therapy MGX-001, on track for regulatory submissions this year and first-in-human trials in 2027. The company also announced the publication of novel CRISPR nuclease MG119-28 research in a prest…
Playboy, Inc. reported Q1 2026 revenue of $30.2 million, up 5% year-over-year, with a net loss of $4.0 million representing a 56% improvement from the previous year. Adjusted EBITDA rose 111% to $5.0 million. The company strengthened its balance sheet by using proceeds from a new China licensing joint venture with UTG Brands to pay down $15 million…
Amwell announced that CFO and COO Mark Hirschhorn will participate in a virtual presentation at the upcoming Needham Technology, Media & Consumer Conference on May 14, showcasing the company's SaaS-based healthcare platform.
